Clinical Trial Update: A Study on the Combination Therapy of Eravacycline for Treating Carbapenem-Resistant Acinetobacter Baumannii Pneumonia

View source ↗

Summary

An ongoing clinical trial is evaluating combination therapy with eravacycline for carbapenem-resistant Acinetobacter baumannii pneumonia. The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• XERAVA (eravacycline)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Pneumonitis, Acinetobacter Baumannii | Status: NOT_YET_RECRUITING